Allergan to concentrate on newer Alphagan P

Optometric Management, Sep 2002

ALPHAGAN DISCONTINUED

Allergan has decided to discontinue the manufacture, sale and marketing of Alphagan, 0.2% and concentrate instead on the improved brand of the product, Alphagan P, 0.15%. Adoption of Alphagan P has been overwhelming, says the company.

Most eyecare professionals report preferring Alphagan P and don't see the need for both products.

Two 12-month clinical studies found that Alphagan P is as effective as Alphagan but has lower rates of some adverse effects, including reduced incidence of ocular allergy. Alphagan P is the first glaucoma drug to use the preservative Purite.